Stay updated with breaking news from Dey Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Many patients would like more education about managing their asthma, which can help to reduce the overuse of short-acting beta-2 agonists.
Adoptive cell therapy (ACT) is a kind of immunotherapy, in which T cells are genetically modified to express a chimeric antigen receptor or T cell receptor.
On July 11, 2022, the United States District Court for the District of Kansas approved a $264 million settlement against Mylan and certain of its subsidiaries in the case In Re EpiPen (Epinephrine Injection, USP) Marketing, ...
On July 11, 2022, the United States District Court for the District of Kansas approved a $264 million settlement against Mylan and certain of its subsidiaries in the case In Re EpiPen...
Epilepsy Pipeline Analysis: 70+ Key Pipeline Therapies and 70+ Key Pharma Players are Looking Out in the Epilepsy Pipeline Landscape